hypoalphalipoproteinemia

hypoalphalipoproteinemia

/hy·po·al·pha·lipo·pro·tein·emia/ (-al″fah-lip″o-pro″te-ne´me-ah)
1. deficiency of high-density (alpha) lipoproteins in the blood.
References in periodicals archive ?
Cerenis Therapeutics is currently pursuing the clinical development of CER-001, an HDL mimetic, as part of a phase II study in post Acute Coronary Syndrome (post-ACS) patients, CARAT, and a phase III study for FPHA (Familial Primary Hypoalphalipoproteinemia, an HDL deficiency due to a genetic defect which is an orphan disease), TANGO.
Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia.
2007) Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family.
Among the clinical entities considered to increase CMR are type 2 diabetes, familial combined hyperlipidemia, familial hypoalphalipoproteinemia, and polycystic ovary syndrome.
Hypoalphalipoproteinemia is a common finding in patients with premature CAD (present in about 5% of these patients).
Primary hypoalphalipoproteinemia is a relatively uncommon familial disorder with low HDL-C levels and generally normal LDL-C and triglyceride levels.
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.
Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
Apo A-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia.
Postprandial lipoprotein(a) response to a single meal containing either saturated or omega-3 polyunsaturated fatty acids in subjects with hypoalphalipoproteinemia.